Dr. Rimoin is the Director of the Center for Global and Immigrant Health and Professor of
Epidemiology at the UCLA Fielding School of Public Health and Infectious Disease Division of the
David Geffen School of Medicine at UCLA. She is an internationally recognized expert on
emerging infections, global health, surveillance systems, and vaccination, and has been
engaged in pandemic preparedness and response for more than two decades.
research in emerging diseases includes the identification of new pathogens in humans and
studying Ebola, especially in the Democratic Republic of Congo. Dr. Rimoin has been a strong
advocate for capacity building in low resource settings and conducting disease surveillance in
Dr. Rimoin has published more than 70 research articles featured in The
New York Times, The Wall Street Journal, Nature and Science. She appears frequently on
television and radio discussing major issues surrounding disease emergence and has recently
been a leading voice on the COVID-19 pandemic in national news for CNN and MSNBC. Dr.
Rimoin earned her BA at Middlebury College, MPH at UCLA and PhD at Johns Hopkins
Dr. Aldrovandi is Chief of the Division of Infectious Diseases at UCLA Mattel Children’s Hospital
and a Professor of Pediatrics at the David Geffen School of Medicine of UCLA. Her research
interests include pediatric HIV, the effects of breast milk on children and infections in
Dr. Aldrovandi is the Laboratory Center Principal Investigator of
the AIDS Clinical Trials Group (ACTG) and the International Maternal Pediatric Adolescent AIDS
Clinical Trials (IMPAACT). She has been continuously funded by the National Institutes of Health
since 1997 and has over 200 publications.